Literature DB >> 18661498

Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible.

Giovanna Lucchini1, Daniele Grioni, Antonella Colombini, Margherita Contri, Carlo De Grandi, Attilio Rovelli, Valentino Conter, Giuseppe Masera, Momcilo Jankovic.   

Abstract

BACKGROUND: Posterior reversible leukoencephalopathy (PRES) is a clinical-radiological event that can affect children undergoing chemotherapy regimen. Studies have shown that it is not always reversible, in spite of its original definition. We analyzed PRES cases which occurred during the last 10 years at our institute to focus on their clinical, radiological and EEG follow-up. PROCEDURES: We analyzed 12 cases of PRES in children who underwent intensive chemotherapy regimens, detailing the acute neurological presentation of the syndrome, their neuro-imaging characteristics (MRI) and EEG findings, in both an acute phase and during follow-up.
RESULTS: All patients survived the acute event, showing a clinical recovery of the acute neurological signs in 1-3 days and normalization of the EEG pattern in a period ranging from 1 to 8 months. During long term follow-up, four patients developed either clinical impairment or EEG-MRI anomalies.
CONCLUSIONS: We suggest that a long term follow-up is necessary to determine the reversibility of the neurological events. Clinical observation, as well as EEG and MRI should be included in follow-up evaluations. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661498     DOI: 10.1002/pbc.21688

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Chika Kawajiri; Satomi Tanaka; Yuhei Nagao; Yasumasa Sugita; Atsuko Yamazaki; Takeharu Kawaguchi; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome.

Authors:  Hui Li; Ying Liu; Jing Chen; Xia Tan; Xiu-Yun Ye; Ming-Sheng Ma; Jian-Ping Huang; Li-Ping Zou
Journal:  World J Pediatr       Date:  2015-06-04       Impact factor: 2.764

3.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

4.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

5.  MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus.

Authors:  Eyal Muscal; Elfrides Traipe; Marietta M de Guzman; Barry L Myones; Robin L Brey; Jill V Hunter
Journal:  Pediatr Radiol       Date:  2010-01-30

6.  High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome.

Authors:  Anna Noè; Barbara Cappelli; Alessandra Biffi; Robert Chiesa; Ilaria Frugnoli; Erika Biral; Valentina Finizio; Cristina Baldoli; Paolo Vezzulli; Fabio Minicucci; Giovanna Fanelli; Rossana Fiori; Fabio Ciceri; Maria Grazia Roncarolo; Sarah Marktel
Journal:  Ital J Pediatr       Date:  2010-02-06       Impact factor: 2.638

7.  MRI Findings in Childhood PRES: What is Different than the Adults?

Authors:  F Y Donmez; P Guleryuz; M Agildere
Journal:  Clin Neuroradiol       Date:  2014-10-08       Impact factor: 3.649

8.  Posterior reversible encephalopathy syndrome after intrathecal methotrexate infusion: a case report and literature update.

Authors:  Efterpi Pavlidou; Evangelos Pavlou; Athanasia Anastasiou; Zoi Pana; Vasiliki Tsotoulidou; Maria Kinali; Emmanuel Hatzipantelis
Journal:  Quant Imaging Med Surg       Date:  2016-10

9.  Tumor lysis syndrome as a risk factor for posterior reversible encephalopathy syndrome in children with hematological malignancies.

Authors:  Daisuke Suzuki; Ryoji Kobayashi; Akihiro Iguchi; Hirozumi Sano; Kenji Kishimoto; Kazue Yasuda; Kunihiko Kobayashi
Journal:  Int J Hematol       Date:  2014-09-13       Impact factor: 2.490

10.  Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Authors:  Brian H Kushner; Shakeel Modak; Ellen M Basu; Stephen S Roberts; Kim Kramer; Nai-Kong V Cheung
Journal:  Cancer       Date:  2013-04-30       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.